Clinical Trial Update: FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FCR (fludarabine, cyclophosphamide, rituximab) versus FC in relapsed chronic lymphocytic leukemia with results posted in January 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2012-01-23